TTIL will support a Phase 2 study to evaluate selective androgen receptor modulator (SARM) drug candidate TT701 as a therapy to improve the symptoms of androgen deficiency
in men with prostate cancer that have undergone a radical prostatectomy procedure;
Early androgen deficiency
in infants and young boys with 47,XXY Klinefelter syndrome.
It would be helpful if health care professionals could identify men with low serum testosterone levels who are likely experiencing symptoms purely from androgen deficiency
and would therefore benefit from treatment.
The aim of the study was to evaluate serum androgen levels and the frequency of late onset hypogonadism (LOH) in patients over 60 years of age with MS and its correlation with parameters of MS by using androgen deficiency
symptoms based on AMS results and affective state of the patient based on BDI scores.
Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency
Little is known about the effect of exercise on performance in healthy partial androgen deficiency
Andropause: An Androgen Deficiency
State in the Ageing Male.
can make a man vulnerable to many medical problems other than sexual disorders.
Hormone replacement therapy can help relieve androgen deficiency
symptoms in men who have below-normal serum testosterone.
But a decrease in fitness levels due to androgen deficiency
, or any other reason, can cause problems.
Because of the resultant androgen deficiency
, secondary male sexual characters including the comb, wattle, fighting behavior and vocalization degenerate and maturity regress to an immature stage.
The symptoms of partial androgen deficiency
in ageing men (PADAM) overlap considerably with those of major depressive disorder.
The diagnosis of hypogonadism relies on clinical features of androgen deficiency
and subnormal serum testosterone levels.
PADAM (Partial Androgen Deficiency
in Aging Males) and IIEF (International Index of Erectile Function) scores, two widely used indicators of male sexual health, have also both reportedly improved with ELJ supplementation.
Topics of these 19 papers include the physiology and pharmacology of ED and its epidemiology, the pharmacology of phosphodiesterase inhibitors, a five-year review of sildenafil citrate, clinical trials of tadalafil and vardenafil, ED assessment and management in primary practice, special cases such as cardiac or diabetic patients and those with depression, therapies other than oral pharmacology, androgen deficiency
, central activation of erection and clinical experience, vacuum devices and implants, prevention of ED, strategies in the management of rapid ejaculation, dysfunction after radical prostatectomy, and the possibilities of oral medications in treating female sexual dysfunction.